Last update 01 Nov 2024

NKT-3964

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NKT-3964
Target
Mechanism
CDK2 modulators(Cyclin-dependent kinase 2 modulators)
Inactive Indication-
Originator Organization-
Active Organization
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Endometrial CarcinomaPhase 1
US
19 Sep 2024
Advanced gastric carcinomaPhase 1
US
19 Sep 2024
Advanced Malignant Solid NeoplasmPhase 1
US
19 Sep 2024
Hormone Receptor Positive Breast AdenocarcinomaPhase 1
US
19 Sep 2024
Human epidermal growth factor 2 negative carcinoma of breastPhase 1
US
19 Sep 2024
Metastatic endometrial cancerPhase 1
US
19 Sep 2024
Metastatic Gastric CarcinomaPhase 1
US
19 Sep 2024
Neoplasm MetastasisPhase 1
US
19 Sep 2024
Platinum-Resistant Ovarian CarcinomaPhase 1
US
19 Sep 2024
PR-positive breast cancerPhase 1
US
19 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free